Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report-Reference-Cited by-同舟云学术

Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report

Published:2015-05-03 Issue:2 Volume:8 Page:144-147
ISSN:1865-5041
Container-title:memo - Magazine of European Medical Oncology
language:en
Short-container-title:memo

Author:

Pfeilstöcker Michael,Weichselbaum Rainer,Mühlberger Helmut,Menschel Elisabeth,Keil Felix

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12254-015-0201-0.pdf

Reference22 articles.

1. Hallek M. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment. Am J Hematol. 2013;88(9):803–16.

2. Zenz T, Mertens D, Döhner H, Stilgenbauer S. Importance of genetics in chronic lymphocytic leukemia. Blood Rev. 2011;25(3):131–7.

3. Zenz T, Benner A, Döhner H, Stilgenbauer S. Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway. Cell Cycle. 2008;7(24):3810–4.

4. Doubek M, Mayer J, Obrtlíková P, et al. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. Eur J Haematol. 2011;87(2):130–7.

5. Byrd JC, Furman RR, Coutre SE, et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med. 2013;369(1):32–42.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bendamustine/cyclophosphamide/fludarabine;Reactions Weekly;2015-07